CS215064B2 - Method of making the derivatives of the thiadiazolotetrahydro-isochiline - Google Patents

Method of making the derivatives of the thiadiazolotetrahydro-isochiline Download PDF

Info

Publication number
CS215064B2
CS215064B2 CS804525A CS452580A CS215064B2 CS 215064 B2 CS215064 B2 CS 215064B2 CS 804525 A CS804525 A CS 804525A CS 452580 A CS452580 A CS 452580A CS 215064 B2 CS215064 B2 CS 215064B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
chloride
mixture
derivatives
mol
Prior art date
Application number
CS804525A
Other languages
Czech (cs)
English (en)
Inventor
William E Bondinell
Gerald R Girard
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Priority to CS81908A priority Critical patent/CS215065B2/cs
Publication of CS215064B2 publication Critical patent/CS215064B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CS804525A 1979-07-02 1980-06-25 Method of making the derivatives of the thiadiazolotetrahydro-isochiline CS215064B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS81908A CS215065B2 (cs) 1979-07-02 1981-02-06 Způsob výroby derivátů oxadiazolotetrahydroisochinolinu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02

Publications (1)

Publication Number Publication Date
CS215064B2 true CS215064B2 (en) 1982-07-30

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
CS804525A CS215064B2 (en) 1979-07-02 1980-06-25 Method of making the derivatives of the thiadiazolotetrahydro-isochiline

Country Status (30)

Country Link
EP (1) EP0023761B1 (es)
JP (1) JPS5610192A (es)
KR (1) KR840000396B1 (es)
AR (1) AR225925A1 (es)
AT (1) ATE6515T1 (es)
AU (1) AU531641B2 (es)
BG (1) BG51250A3 (es)
CA (1) CA1129415A (es)
CS (1) CS215064B2 (es)
DD (1) DD151750A5 (es)
DE (1) DE3066826D1 (es)
DK (1) DK151029C (es)
ES (1) ES492971A0 (es)
FI (1) FI67221C (es)
GR (1) GR69206B (es)
HU (1) HU179382B (es)
IE (1) IE50290B1 (es)
IL (1) IL60426A (es)
IN (1) IN160542B (es)
MX (1) MX6317E (es)
NO (1) NO801951L (es)
NZ (1) NZ194156A (es)
PH (1) PH17042A (es)
PL (2) PL127098B1 (es)
PT (1) PT71458A (es)
RO (1) RO79707A (es)
SU (1) SU1072809A3 (es)
YU (1) YU171180A (es)
ZA (1) ZA802987B (es)
ZW (1) ZW14680A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
IL60426A0 (en) 1980-09-16
AR225925A1 (es) 1982-05-14
IE801352L (en) 1981-01-02
MX6317E (es) 1985-04-01
HU179382B (en) 1982-10-28
IE50290B1 (en) 1986-03-19
SU1072809A3 (ru) 1984-02-07
ES8105736A1 (es) 1981-06-01
ATE6515T1 (de) 1984-03-15
IN160542B (es) 1987-07-18
FI802112A (fi) 1981-01-03
DE3066826D1 (en) 1984-04-12
PL127098B1 (en) 1983-09-30
DK274280A (da) 1981-01-03
CA1129415A (en) 1982-08-10
BG51250A3 (en) 1993-03-15
FI67221C (fi) 1985-02-11
ZA802987B (en) 1981-05-27
DD151750A5 (de) 1981-11-04
KR830002791A (ko) 1983-05-30
YU171180A (en) 1983-09-30
NZ194156A (en) 1983-03-15
PL230619A1 (es) 1981-12-11
AU531641B2 (en) 1983-09-01
PL225377A1 (es) 1981-08-21
ES492971A0 (es) 1981-06-01
EP0023761B1 (en) 1984-03-07
DK151029C (da) 1988-03-07
KR840000396B1 (ko) 1984-03-30
EP0023761A1 (en) 1981-02-11
PH17042A (en) 1984-05-17
NO801951L (no) 1981-01-05
FI67221B (fi) 1984-10-31
GR69206B (es) 1982-05-07
IL60426A (en) 1984-03-30
RO79707A (ro) 1982-08-17
JPS5610192A (en) 1981-02-02
DK151029B (da) 1987-10-12
PT71458A (en) 1980-07-01
AU5967780A (en) 1981-01-15
ZW14680A1 (en) 1980-09-24

Similar Documents

Publication Publication Date Title
JP2656699B2 (ja) 置換ベンジルアミノキヌクリジン
KR900006853B1 (ko) 약리학적으로 활성인 피라졸로/4,3-c/피리딘의 제조방법
NO315704B1 (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse
KR20040079987A (ko) 클로피도그렐 히드로클로라이드의 다형체 및 이의 항혈전화합물로서의 용도
CZ20021416A3 (cs) Derivát imidazopyridinu jako inhibitor fosfodiesterázy VII, jeho pouľití a farmaceutický prostředek, který ho obsahuje
NZ211272A (en) Pharmaceutical compositions containing quaternary 3,4-dihydroisoquinolinium salts
EP0047536A2 (en) Substituted propylamines
JPS6126546B2 (es)
EP0175525B1 (en) 7-[2-(Dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
EP0214740A2 (en) Dopamine-beta-hydroxylase inhibitors
US4352809A (en) Method of producing alpha2 antagonism
AU600480B2 (en) Ester prodrugs of dopamine-beta-hydroxylase inhibitors
US4091105A (en) 2-Imino-3-aminothiazolidines and indoleamine-N-methyltransferase inhibition
CN105339369B (zh) 一种吡嗪并[1,2‑a]吲哚化合物及其制备方法和在药物中的应用
CS215064B2 (en) Method of making the derivatives of the thiadiazolotetrahydro-isochiline
CZ20021251A3 (cs) Derivát imidazolu jako inhibitor fosfodiesterázy VII, jeho pouľití a farmaceutický prostředek, který ho obsahuje
US4585776A (en) 4-chloro-furo-(3,4-c)-pyridine derivatives process for their preparation and therapeutical compositions containing them
CZ321095A3 (en) Heterocyclic compounds
US4707484A (en) Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
US4242346A (en) Bis-2N-alkylene tetrahydroisoquinoline compounds
DK162050B (da) Pyrazolderivater med ergolinskelet eller salte deraf, deres fremstilling, farmaceutiske praeparater indeholdende disse og fremgangsmaade til fremstilling af de farmaceutiske praeparater
US4258049A (en) Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
JPS61172864A (ja) アルキン誘導体
US3005818A (en) 1-phenyl-2, 3-dimethyl-4-morpholino methyl pyrazolone-(5) compounds
CS215065B2 (cs) Způsob výroby derivátů oxadiazolotetrahydroisochinolinu